Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in w...

Full description

Saved in:
Bibliographic Details
Main Authors: Marouane Boukhris, Salvatore Davide Tomasello, Francesco Marzà, Sonia Bregante, Francesca Romana Pluchinotta, Alfredo Ruggero Galassi
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2014/413920
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554522120028160
author Marouane Boukhris
Salvatore Davide Tomasello
Francesco Marzà
Sonia Bregante
Francesca Romana Pluchinotta
Alfredo Ruggero Galassi
author_facet Marouane Boukhris
Salvatore Davide Tomasello
Francesco Marzà
Sonia Bregante
Francesca Romana Pluchinotta
Alfredo Ruggero Galassi
author_sort Marouane Boukhris
collection DOAJ
description Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.
format Article
id doaj-art-cb79d7fe2a7f423a8343fb5a0d194187
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-cb79d7fe2a7f423a8343fb5a0d1941872025-02-03T05:51:18ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/413920413920Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative ReviewMarouane Boukhris0Salvatore Davide Tomasello1Francesco Marzà2Sonia Bregante3Francesca Romana Pluchinotta4Alfredo Ruggero Galassi5Department of Medical Sciences and Pediatrics, Catheterization Laboratory and Cardiovascular Interventional Unit, Cannizzaro Hospital, University of Catania, Via Messina 829, 95126 Catania, ItalyDepartment of Medical Sciences and Pediatrics, Catheterization Laboratory and Cardiovascular Interventional Unit, Cannizzaro Hospital, University of Catania, Via Messina 829, 95126 Catania, ItalyDepartment of Medical Sciences and Pediatrics, Catheterization Laboratory and Cardiovascular Interventional Unit, Cannizzaro Hospital, University of Catania, Via Messina 829, 95126 Catania, ItalyIRCCS Policlinico S. Donato, Via Morandi 30, 20097 Milano, ItalyIRCCS Policlinico S. Donato, Via Morandi 30, 20097 Milano, ItalyDepartment of Medical Sciences and Pediatrics, Catheterization Laboratory and Cardiovascular Interventional Unit, Cannizzaro Hospital, University of Catania, Via Messina 829, 95126 Catania, ItalyCoronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.http://dx.doi.org/10.1155/2014/413920
spellingShingle Marouane Boukhris
Salvatore Davide Tomasello
Francesco Marzà
Sonia Bregante
Francesca Romana Pluchinotta
Alfredo Ruggero Galassi
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
International Journal of Endocrinology
title Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
title_full Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
title_fullStr Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
title_full_unstemmed Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
title_short Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
title_sort coronary heart disease in postmenopausal women with type ii diabetes mellitus and the impact of estrogen replacement therapy a narrative review
url http://dx.doi.org/10.1155/2014/413920
work_keys_str_mv AT marouaneboukhris coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview
AT salvatoredavidetomasello coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview
AT francescomarza coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview
AT soniabregante coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview
AT francescaromanapluchinotta coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview
AT alfredoruggerogalassi coronaryheartdiseaseinpostmenopausalwomenwithtypeiidiabetesmellitusandtheimpactofestrogenreplacementtherapyanarrativereview